Organización Sanitaria Integrada Debagoiena
Organización de Osakidetza
![Foto de Ramón](/img/nophoto.png)
Ramón
San Miguel Elcano
Publicaciones en las que colabora con Ramón San Miguel Elcano (12)
2019
-
Survival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments
Expert Review of Gastroenterology and Hepatology, Vol. 13, Núm. 7, pp. 699-708
2018
-
Economic evaluation of a population strategy for the treatment of chronic hepatitis C with direct-acting antivirals
Revista Espanola de Enfermedades Digestivas, Vol. 110, Núm. 10, pp. 621-628
2017
-
Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients
Expert Review of Gastroenterology and Hepatology, Vol. 11, Núm. 1, pp. 85-93
2016
-
Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 16, Núm. 2, pp. 285-294
-
Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis
Medicina Clinica, Vol. 146, Núm. 2, pp. 61-64
-
Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence
Expert Review of Gastroenterology and Hepatology, Vol. 10, Núm. 11, pp. 1289-1303
2015
-
Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C
Gut, Vol. 64, Núm. 8, pp. 1277-1288
2014
-
Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: A systematic review of published literature
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 14, Núm. 3, pp. 387-402
2013
-
Cost-effectiveness analysis of triple therapy with protease inhibitors in treatment-naive hepatitis C patients
PharmacoEconomics, Vol. 31, Núm. 10, pp. 919-931
2011
2010
-
Role of "health-related quality of life" measurements in the design of drug clinical trials
Farmacia Hospitalaria, Vol. 34, Núm. 1, pp. 16-22
2003
-
Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon
Alimentary Pharmacology and Therapeutics, Vol. 17, Núm. 6, pp. 765-773